INFI

Infinity Pharmaceuticals, Inc. Press Releases

$8.7
*  
0.04
0.46%
Get INFI Alerts
*Delayed - data as of Aug. 3, 2015 12:21 ET  -  Find a broker to begin trading INFI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    INFI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Infinity Announces the Date of Its Second Quarter 2015 Financial Results Conference Call and Webcast
7/30/2015 8:00:00 AM - Business Wire
▲0.23 % Price Change since this news event. The Volume Ratio is 0.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Infinity to Participate in Two Upcoming Conferences
7/21/2015 8:00:00 AM - Business Wire
▼-11.13 % Price Change since this news event. The Volume Ratio is 1.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
5/31/2015 9:30:00 AM - Business Wire
▼-32.87 % Price Change since this news event. The Volume Ratio is 2.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Infinis CEO Interviewed on Full-Year 2015 Results
5/28/2015 2:59:00 AM - PR Newswire


Infinity to Participate in Three Investor Conferences in June
5/27/2015 8:00:00 AM - Business Wire
▼-33.03 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Infinity Reports Preclinical Data for Duvelisib Demonstrating Synergy with Standard-of-Care Therapies and Emerging Agents in Development for the Treatment of Hematologic Malignancies
5/26/2015 8:00:00 AM - Business Wire
▼-32.30 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Infinity Announces New Data for Duvelisib to Be Presented at the 2015 American Society of Clinical Oncology Annual Meeting
5/13/2015 5:20:00 PM - Business Wire
▼-30.23 % Price Change since this news event. The Volume Ratio is 0.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day